Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

Ertapenem is active against extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae organisms but inactive against Pseudomonas aeruginosa and Acinetobacter baumannii. Due to a lack of therapeutic data for ertapenem in the treatment of ESBL bloodstream infections (BSIs), group 2 carbapenems...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Collins, Vicki L., Marchaim, Dror, Pogue, Jason M., Moshos, Judy, Bheemreddy, Suchitha, Sunkara, Bharath, Shallal, Alex, Chugh, Neelu, Eiseler, Sara, Bhargava, Pragati, Blunden, Christopher, Lephart, Paul R., Memon, Babar Irfan, Hayakawa, Kayoko, Abreu-Lanfranco, Odaliz, Chopra, Teena, Munoz-Price, L. Silvia, Carmeli, Yehuda, Kaye, Keith S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318320/
https://ncbi.nlm.nih.gov/pubmed/22290982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05913-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados